Birger Brodin Larsen

Birger Brodin Larsen

Lic. Scient. (Ph.D.)

1989 …2019

Research activity per year

Network

Philipp Berndt

  • Leibniz Institut für Molekulare Physiogie, Campus Berlin-Buch, Berlin, Germany

External person

Ingolf Blasig

  • Leibniz Institut für Molekulare Physiogie, Campus Berlin-Buch, Berlin, Germany

External person

Lassina Badolo

  • Neuroscience Drug Discovery Denmark, H. Lundbeck A/S, 9 Ottiliavej, 2500 Copenhagen-Valby, Denmark

External person

René Holm

  • H. Lundbeck A/S

External person

Simon Groth

  • Institut for Medicin og Sundhedsteknologi
  • Det Teknisk-Naturvidenskabelige Fakultet, Aalborg Universitet

External person

Helle Bach Søndergaard

  • FARMA
  • University of Copenhagen

External person

Rene Holm

  • H.Lundbeck A/S

External person

K A Rytved

  • University of Copenhagen

External person

Rasmus Madelung

  • Institut for Farmaci

External person

Kristine Langthaler

  • H. Lundbeck A/S

External person

Anne Jensen

  • Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen

External person

Piotr Siupka

  • Institut for Biomedicin - Forskning og uddannelse, Vest

External person

Morten Schallburg Nielsen

  • Institut for Biomedicin - Forskning og uddannelse, Vest

External person

Rene Holm

  • H. Lundbeck A/S

External person

Klaus Gjervig Jensen

  • H. Lundbeck A/S

External person

Júlia Rodríguez Sendra

  • Department of Molecular Drug Research, University of Copenhagen

External person

Rene Holm

  • H. Lundbeck A/S

External person

Ignacio A Romero

  • Open University Milton Keynes

External person

Rasmus Koldborg Holm

  • H. Lundbeck A/S

External person

Jukka Mönkkönen

  • University of Kuopio

External person

Hazel C Jones

  • Gagle Brook House

External person

Peter Ifversen

  • Coloplast A/s

External person

Elin Eneberg

  • H. Lundbeck A/S

External person

Peder Søndergaard Madsen

  • Institut for Biomedicin - Forskning og uddannelse, Vest

External person

Anne-Marie Jacobsen

  • H. Lundbeck A/S

External person

H Sari

  • Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen

External person

H.M. Oppers-Tiemissen

  • Schering-Plough Corporation

External person

Andreas Tue Ingemann Jensen

  • The Hevesy Laboratory

External person

Markus Schwaninger

  • University of Lübeck

External person

Ralf Mols

  • KU Leuven

External person

Christina Sveigaard

  • H. Lundbeck A/S

External person

K. B. Ewon

  • H. Lundbeck A/S

External person

Martijn Rooseboom

  • Schering-Plough Corporation

External person

Karin Lykke-Hartmann

  • Institut for Biomedicin - Medicinsk Biokemi

External person

Pernille Lindskov Krog

  • Danish University of Pharmaceutical Sciences

External person

M A Kall

  • Department of Early Development Pharmacokinetics, H. Lundbeck A/S

External person

John Greenwood

  • UCL Institute of Ophthalmology
  • University College London

External person

Torben Moos

  • Laboratoriet for Neurobiologi

External person

Anne Højland

  • Institut for Biomedicin - Forskning og uddannelse, Vest

External person

Dirk Tourwé

  • Vrije Universiteit Brussel

External person

Simran Kaur

  • University of Melbourne

External person

Rose Hayeshi

  • AstraZenecha

External person

Daniela Vullo

  • Università degli Studi di Firenze

External person

Mette Carstensen

  • Institut for Farmaci

External person

Alan W Stitt

  • Queen's University Belfast

External person

Nathalie Maubon

  • Solvay Pharmaceuticals Company

External person

Egbert Hovenkamp

  • Unilever Food and Health Research Institute

External person

Eva G.E. Ragnarsson

  • Uppsala University

External person

C. Birer

  • Department of Drug Design and Pharmacology, University of Copenhagen

External person

L Langthaler

  • Biologics and Pharmaceutical Science, H. Lundbeck A/S, Ottiliavej 9, 2500, Valby, Denmark.

External person

Lina Fossati

  • Solvay Pharmaceuticals Company

External person

Chantal Masungi

  • Tibotec BVBA

External person

Klaus G. Jensen

  • H. Lundbeck A/S

External person

Pascale Anderle

  • Laboratory of Experimental Cancer Research

External person

R Holm

  • Biologics and Pharmaceutical Science, H. Lundbeck A/S, Ottiliavej 9, 2500, Valby, Denmark.

External person

Jon Våbenø

  • UiT The Arctic University of Norway

External person

Flemming Madsen

  • Coloplast A/s

External person

Michel Khrestchatisky

  • CNRS
  • Aix-Marseille Université

External person

Karrin Lykke-Hartmann

  • Aarhus University

External person

Caitriona O´Driscoll

  • University College Cork

External person

Bjørn Holst

  • Bioneer A/S (Biz)

External person

René Holm

  • Biologics and Pharmaceutical Science, H. Lundbeck A/S, Ottiliavej 9, 2500, Valby, Denmark.

External person

Per Arthursson

  • Uppsala University

External person

Gert Fricker

  • Heidelberg University
  • Heidelberg University 

External person

Claudiu T Supuran

  • Università degli Studi di Firenze

External person

Carsten Uhd Nielsen

  • University of Southern Denmark

External person

René Holm

  • H. Lundbeck A/S

External person

Andrea Scozzafava

  • Università degli Studi di Firenze

External person

K. V. Christensen

  • H. Lundbeck A/S

External person

René Holm

  • H.Lundbeck A/S

External person

Timo Korjamo

  • University of Kuopio

External person

Helle Bach Søndergaard

  • Danish Multiple Sclerosis Research Center
  • University of Copenhagen

External person

Karen Fisher

  • University College Cork

External person

Jan Amstrup

  • Zoophysiological Laboratory, August Krogh Institute, University of Copenhagen, Universitetsparken 13, DK-2100, Copenhagen Ø

External person

Torben Moos

  • Institut for Medicin og Sundhedsteknologi
  • Faggruppen for Biomedicin
  • Det Sundhedsvidenskabelige Fakultet, Københavns Universitet
  • Laboratoriet for Neurobiologi

External person

Steven Ballet

  • Vrije Universiteit Brussel

External person

Pieter J Gaillard

  • 2-BBB Medicines BV

External person

Ingrid Hausser

  • Universitäts-Hautklinik

External person

K. G. Jensen

  • H. Lundbeck A/S

External person

Stephen T Buckley

  • Novo Nordisk A/S

External person

Stephen Buckley

  • University of York

External person

R. Larsen

  • H. Lundbeck A/S

External person

René Holm

  • Biologics and Pharmaceutical Science, H. Lundbeck A/S, Ottiliavej 9, 2500, Valby, Denmark.

External person

M. A. Kall

  • H. Lundbeck A/S

External person

Heiko Manninga

  • NEUWAY Pharma GmbH

External person

Dino Montanari

  • H. Lundbeck A/S

External person

Lars Olsen

  • Danish University of Pharmaceutical Sciences

External person

S Abdulhadi

  • Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen

External person

Tue Søborg

  • Lægemiddelstyrelsen

External person